Evidence map›Paper›PMID 12761087›Full record

ArticleInfection and immunity2003

T cells are required for host protection against Brugia malayi but need not produce or respond to interleukin-4.

L Spencer, L Shultz, T V Rajan

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

L SpencerDepartment of Pathology, University of Connecticut Health Center, Farmington 06030, USA.
L Shultz
T V Rajan
UConn Health · USJackson Laboratory · US

Funding

BASIC IMMUNOLOGY &IMMUNOLOGIC CELL INJURYT32AI007080 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ADLER, ADAM J, VELLA, ANTHONY T · 1985 to 2012
$1.4M
GROWTH OF B MALAYI IN MURINE MODELS--ROLE OF NK CELLSR01AI042362 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RAJAN, THIRUCHANDURAI V · 1998 to 2001
$408k
NIAID NIH HHS AI 39705NIAID NIH HHS AI 42362NIAID NIH HHS T32 AI007080NIAID NIH HHS T32 AI 07080
6 · The paper itself

Abstract

T cells are known to be required for host protection in mouse models of Brugia malayi infection. Several independent studies in murine models have also highlighted the rapid induction of Th2-like responses after infection with B. malayi or B. pahangi. Previous data from our laboratory have described a significant increase in permissiveness in the absence of interleukin-4 (IL-4), the "prototypical" Th2 cytokine, involved in both the induction and maintenance of Th2 responses. These observations led to our hypothesis that T cells involved in murine host protection would respond to IL-4 signaling and differentiate into cells of the "type 2" phenotype. As such, these cells would presumably also act as major sources of IL-4. To investigate these hypotheses, we performed several adoptive transfers in which we controlled the cell population(s) able to produce or respond to IL-4. We show here that, in contrast to our original hypotheses, IL-4 production and IL-4 receptor expression by T cells are both dispensable for T-cell-mediated host protection. Instead, our data imply that T cells may be required for eosinophil accumulation at the site of infection.

Indexed as

Brugia malayiAnimalsEosinophilsFilariasisInterleukin-13Interleukin-4MiceMice, Inbred BALB CMice, SCIDReceptors, Interleukin-4STAT6 Transcription FactorT-LymphocytesTrans-ActivatorsInterleukin-13Interleukin-4Receptors, Interleukin-4Stat6 protein, mouseSTAT6 Transcription FactorTrans-Activators

Identifiers

PMID12761087
PMCPMC155764
OpenAlexW2121576952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.